Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
COVID-19
NK cells
SARS-CoV-2 infection
T lymphocytes
dendritic cells
interleukin-22
interleukin-22 receptor
monocytes
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
09
2021
accepted:
07
03
2022
entrez:
15
4
2022
pubmed:
16
4
2022
medline:
19
4
2022
Statut:
epublish
Résumé
The new pandemic virus SARS-CoV-2 is characterized by uncontrolled hyper-inflammation in severe cases. As the IL-22/IL-22R1 axis was reported to be involved in inflammation during viral infections, we characterized the expression of IL-22 receptor1, IL-22 and IL-22 binding protein in COVID-19 patients. Blood samples were collected from 19 non-severe and 14 severe patients on the day they presented (D0), at D14, and six months later, and from 6 non-infected controls. The IL-22R1 expression was characterized by flow cytometry. Results were related to HLA-DR expression of myeloid cells, to plasma concentrations of different cytokines and chemokines and NK cells and T lymphocytes functions characterized by their IFN-γ, IL-22, IL-17A, granzyme B and perforin content. The numbers of IL-22R1
Identifiants
pubmed: 35422799
doi: 10.3389/fimmu.2022.769839
pmc: PMC9004465
doi:
Substances chimiques
Chemokines
0
HLA-DR Antigens
0
Interleukin-17
0
Receptors, Interleukin
0
interleukin-22 receptor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
769839Informations de copyright
Copyright © 2022 Albayrak, Orte Cano, Karimi, Dogahe, Van Praet, Godefroid, Del Marmol, Grimaldi, Bondue, Van Vooren, Mascart and Corbière.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Immunol. 2019 Aug 30;10:2035
pubmed: 31543877
Immunohorizons. 2018 Jul 5;2(6):198-207
pubmed: 31022687
BMC Pulm Med. 2009 Aug 11;9:39
pubmed: 19671154
Front Immunol. 2020 Sep 17;11:2148
pubmed: 33042126
Front Immunol. 2019 Jun 11;10:1325
pubmed: 31244860
J Immunol. 2017 Mar 1;198(5):2182-2190
pubmed: 28100680
Microb Pathog. 2021 Apr;153:104799
pubmed: 33609650
Front Immunol. 2020 Jun 23;11:1512
pubmed: 32655581
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Hepatol Int. 2019 Jan;13(1):75-83
pubmed: 30467624
Antiviral Res. 2017 Jun;142:68-75
pubmed: 28322925
Adv Biol Regul. 2020 Aug;77:100737
pubmed: 32773100
J Immunol. 2009 Nov 15;183(10):6639-45
pubmed: 19864591
Clin Exp Immunol. 2015 Aug;181(2):219-29
pubmed: 25880879
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620933508
pubmed: 32539627
Open Biol. 2020 Sep;10(9):200160
pubmed: 32961074
Mucosal Immunol. 2017 Jul;10(4):1069-1081
pubmed: 28247861
Front Immunol. 2016 May 30;7:211
pubmed: 27303405
Int J Mol Sci. 2016 Aug 11;17(8):
pubmed: 27529227
J Clin Invest. 2020 Dec 1;130(12):6290-6300
pubmed: 32784290
Cell Host Microbe. 2020 Jun 10;27(6):863-869
pubmed: 32464098
J Mol Med (Berl). 2016 May;94(5):523-34
pubmed: 26923718
Comput Struct Biotechnol J. 2021;19:976-988
pubmed: 33558827
Cytokine Growth Factor Rev. 2014 Jun;25(3):257-71
pubmed: 24856143
Respir Res. 2019 Aug 15;20(1):184
pubmed: 31416461
Am J Respir Cell Mol Biol. 2004 Aug;31(2):220-6
pubmed: 15039135
Am J Respir Crit Care Med. 2010 Sep 15;182(6):848-54
pubmed: 20508213
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Front Immunol. 2020 Jun 09;11:1160
pubmed: 32582219
Am J Pathol. 2021 Jan;191(1):4-17
pubmed: 32919977
J Clin Invest. 2020 Sep 1;130(9):4694-4703
pubmed: 32463803
Immunol Res. 2012 Sep;53(1-3):41-57
pubmed: 22430559
Gastroenterology. 2020 Oct;159(4):1417-1430.e3
pubmed: 32585307
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
Immunity. 2020 Oct 13;53(4):864-877.e5
pubmed: 32791036
Geroscience. 2020 Aug;42(4):1051-1061
pubmed: 32556942
Eur Respir J. 2016 Apr;47(4):1277-80
pubmed: 26846835
J Immunol Res. 2016;2016:1475435
pubmed: 27478854
Am J Pathol. 2013 Apr;182(4):1286-96
pubmed: 23490254
Leukemia. 2008 Aug;22(8):1595-603
pubmed: 18509351
Blood. 2011 Jan 13;117(2):575-84
pubmed: 20971950
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32353870
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Cytokine. 2020 Sep;133:155151
pubmed: 32544563
Cytokine Growth Factor Rev. 2020 Aug;54:62-75
pubmed: 32513566
Int Immunopharmacol. 2021 Apr;93:107364
pubmed: 33486333
J Infect Dis. 2020 Aug 4;222(5):746-754
pubmed: 32563194
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Nat Immunol. 2011 May;12(5):383-90
pubmed: 21502992
Front Immunol. 2018 Sep 25;9:2209
pubmed: 30319650
Immunol Rev. 2014 Jul;260(1):129-44
pubmed: 24942687
Cell Mol Immunol. 2021 Mar;18(3):604-612
pubmed: 33060840
Eur Respir J. 2015 Sep;46(3):771-82
pubmed: 26250498